Chillo Pilly, Mashili Fredirick, Kwesigabo Gideon, Ruggajo Paschal, Kamuhabwa Appolinary
Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
East African Centre of Excellence in Cardiovascular Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Front Cardiovasc Med. 2022 Mar 25;9:849007. doi: 10.3389/fcvm.2022.849007. eCollection 2022.
Cardiovascular disease (CVD) contribute the largest mortality burden globally, with most of the deaths (80% of all deaths) occurring in low and middle-income countries (LMICs), including Tanzania. Despite the increasing burden, to date, CVD research output is still limited in Tanzania, as it is for many sub-Saharan Africa (SSA) countries. This trend hinders the establishment of locally informed CVD management and policy changes. Here, we aim to review the existing gaps while highlighting the available opportunities for a sustainable CVD research strategy in Tanzania.
A rapid review of available literature on CVD research in SSA was conducted, with emphasis on the contribution of Tanzania in the world literature of CVD. Through available literature, we identify strategic CVD research priorities in Tanzania and highlight challenges and opportunities for sustainable CVD research output.
Shortage of skilled researchers, inadequate research infrastructure, limited funding, and lack of organized research strategies at different levels (regional, country, and institutional) are among the existing key bottlenecks contributing to the low output of CVD research in Tanzania. There is generally strong global, regional and local political will to address the CVD epidemic. The establishment of the East African Centre of Excellence in Cardiovascular Sciences (EACoECVS) offers a unique opportunity for setting strategies and coordinating CVD research and training for Tanzania and the East African region.
There is a light of hope for long-term sustainable CVD research output from Tanzania, taking advantage of the ongoing activities and plans for the evolving EACoECVS. The Tanzanian experience can be taken as a lesson for other SSA countries.
心血管疾病(CVD)在全球造成了最大的死亡负担,其中大多数死亡(占所有死亡人数的80%)发生在包括坦桑尼亚在内的低收入和中等收入国家(LMICs)。尽管负担日益加重,但迄今为止,坦桑尼亚的心血管疾病研究产出仍然有限,撒哈拉以南非洲(SSA)的许多国家也是如此。这种趋势阻碍了基于当地情况的心血管疾病管理的建立和政策变革。在此,我们旨在审视现有的差距,同时强调坦桑尼亚可持续心血管疾病研究战略的可用机会。
对撒哈拉以南非洲心血管疾病研究的现有文献进行了快速回顾,重点关注坦桑尼亚在世界心血管疾病文献中的贡献。通过现有文献,我们确定了坦桑尼亚心血管疾病研究的战略重点,并强调了可持续心血管疾病研究产出的挑战和机会。
熟练研究人员短缺、研究基础设施不足、资金有限以及不同层面(区域、国家和机构)缺乏有组织的研究战略,是导致坦桑尼亚心血管疾病研究产出低的现有关键瓶颈。全球、区域和地方普遍有强烈的政治意愿来应对心血管疾病流行问题。东非心血管科学卓越中心(EACoECVS)的建立为坦桑尼亚和东非地区制定战略以及协调心血管疾病研究与培训提供了独特机会。
利用东非心血管科学卓越中心正在开展的活动和不断发展的计划,坦桑尼亚长期可持续的心血管疾病研究产出有望实现。坦桑尼亚的经验可为其他撒哈拉以南非洲国家提供借鉴。